Literature DB >> 2158917

Studies on autoimmunity for initiation of beta-cell destruction. V. Decrease of macrophage-dependent T lymphocytes and natural killer cytotoxicity in silica-treated BB rats.

K Amano1, J W Yoon.   

Abstract

Administration of silica, which is selectively toxic to macrophages, to young BB rats resulted in the prevention of insulitis and diabetes. However, the mechanism leading to the prevention of an autoimmune process in silica-treated BB rats is not known. This study was undertaken to investigate the mechanism involved in prevention of insulitis and diabetes. Neonates of diabetes-prone BB (DPBB) rats injected with concanavalin A (ConA)-activated spleen cells from silica-treated DPBB (STDPBB) rats did not develop insulitis or diabetes, whereas DPBB neonates injected with ConA-activated spleen cells from the untreated DPBB rats developed both insulitis and diabetes. Not only was there a decrease of natural killer (NK) cell activity in splenocytes from STDPBB rats, but there was also a significant reduction in the number of immunocytes such as T lymphocytes (helper/inducer and cytotoxic/suppressor) and NK cells. The number of macrophages in both spleen and peripheral blood was significantly decreased in STDP rats compared with untreated DP rats. In contrast to the changes in T lymphocytes and NK cell activity, there was no change in target beta-cells in STDPBB rats with regard to the susceptibility to adoptive transfer of insulitis. It is concluded that the prevention of insulitis and diabetes in STDPBB rats is due to a decrease in macrophage-dependent T lymphocytes and NK cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158917     DOI: 10.2337/diab.39.5.590

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

Review 1.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 2.  Adaptation of intestinal nutrient transport in health and disease. Part II.

Authors:  A B Thomson; G Wild
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

3.  Macrophages from nonobese diabetic mouse have a selective defect in IFN-γ but not IFN-α/β receptor pathway.

Authors:  Myung-Shik Lee; Hyung-Joon Kwon; Hun Sik Kim
Journal:  J Clin Immunol       Date:  2012-03-07       Impact factor: 8.317

Review 4.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

5.  Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  H S Baek; J W Yoon
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  Studies on autoimmunity for initiation of beta-cell destruction. VIII. Pancreatic beta-cell dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats.

Authors:  I Y Ko; S H Ihm; J W Yoon
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

7.  Studies on autoimmunity for initiation of beta-cell destruction. X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the diabetes-prone BB rat.

Authors:  I Y Ko; H S Jun; G S Kim; J W Yoon
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

8.  Neopterin as a new biomarker for the evaluation of occupational exposure to silica.

Authors:  Zeynep Zubeyde Altindag; Terken Baydar; Askin Isimer; Gonul Sahin
Journal:  Int Arch Occup Environ Health       Date:  2003-02-26       Impact factor: 3.015

9.  The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice.

Authors:  H S Jun; C S Yoon; L Zbytnuik; N van Rooijen; J W Yoon
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

Review 10.  Immunity to the Dual Threat of Silica Exposure and Mycobacterium tuberculosis.

Authors:  Petr Konečný; Rodney Ehrlich; Mary Gulumian; Muazzam Jacobs
Journal:  Front Immunol       Date:  2019-01-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.